Master trial seeks to aid drug development for pediatric AMLMay 12, 2019AMLLeukemia, Myelodysplasia, TransplantationPediatrics
Researchers propose new risk groups for NK-AMLMay 8, 2019AMLLeukemia, Myelodysplasia, Transplantation
Combo proves most effective in HMA-naive, higher-risk MDSMay 3, 2019Myelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationAML
More abnormal cells linked to poorer ASCT outcomes in MDSMay 3, 2019TransplantationMyelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
FDA approves ivosidenib frontline for certain AML patientsMay 3, 2019AMLLeukemia, Myelodysplasia, Transplantation
LentiGlobin reduces transfusion dependence in young thalassemia patientsMay 3, 2019Bleeding DisordersAnemiaPediatricsGene Therapy
